Table 2.

MDCT findings of AMI in survived and died patients

MDCT findings	All patients with AMI (n = 33)	Survived patients with AMI (n = 15)	Died patients with AMI (n = 18)	P valuea
MDCT signs
Bowel wall thickening	14 (42.4%)	8 (53.3%)	6 (33.3%)	0.211
Bowel wall edema	3 (9.1%)	2 (13.3%)	1 (5.6%)	0.430
Bowel-loop dilatation	14 (42.4%)	6 (40%)	8 (44.4%)	0.797
Bowel wall thinning	5 (15.2%)	1 (6.7%)	4 (22.2%)	0.229
Increased bowel wall attenuation	1 (3%)	0	1 (5.6%)	0.545
Decreased bowel wall enhancement	21 (63.6%)	7 (46.7%)	14 (77.8%)	0.068
PPMVG	6 (18.2%)	0	6 (33.3%)	0.017
Mesenteric haziness or fluid	4 (12.1%)	2 (13.3%)	2 (11.1%)	0.626
Mesenteric vascular engorgement	18 (54.5%)	10 (66.7%)	8 (44.4%)	0.202
Free intraperitoneal gas	2 (6.1%)	1 (6.7%)	1 (5.6%)	0.710
Free intraperitoneal fluid	5 (15.2%)	3 (20%)	2 (11.1%)	0.409
Solid organ infarction	8 (24.2%)	5 (33.3%)	3 (16.7%)	0.240
MDCT angiographic findings
Degree of SMA stenosis
Mild (<50%)	3 (9.1%)	2 (13.3%)	1 (5.6%)	0.430
Moderate (50% to <75%)	5 (15.2%)	2 (13.3%)	3 (16.7%)	0.591
Severe (75% to <100%)	9 (27.3%)	6 (40%)	3 (16.7%)	0.135
Complete occlusion (100%)	16 (48.5%)	5 (33.3%)	11 (61.1%)	0.112
Region of SMA thromboembolism
Region I	2 (6.1%)	1 (6.7%)	1 (5.6%)	0.710
Region II	4 (12.1%)	1 (6.7%)	3 (16.7%)	0.374
Region III	5 (15.2%)	3 (20%)	2 (11.1%)	0.409
Region IV	2 (6.1%)	1 (6.7%)	1 (5.6%)	0.710
Region II + III	4 (12.1%)	3 (20%)	1 (5.6%)	0.234
Region III + IV	8 (24.2%)	4 (26.7%)	4 (22.2%)	0.541
Region II + III + IV	3 (9.1%)	2 (13.3%)	1 (5.6%)	0.430
Region I + II + III + IV	5 (15.2%)	0	5 (27.8%)	0.036

AMI, acute mesenteric ischemia; MDCT, multidetector computed tomography; PPMVG, pneumatosis and/or portomesenteric venous gas; SMA, superior mesenteric artery.

^aComparison between survived and died patients.